- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 6, 2026 | 46.69M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 51.58M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 10.21M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $1.47M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.84M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $30.51M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $2.36M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$7.53M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$56.07M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$52.14M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $23.75M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $16.84M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $189.4M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $207.03M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $36.49M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $23.3M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $181.87M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $150.96M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.41 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.42 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.48 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$0.42 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.38M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $2.11M |
| Net Income | Q1 2026 · Mar 31, 2026 | $20.12M |
| Net Income | Q1 2026 · Dec 31, 2025 | −$93.13M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$6.35M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$3.98M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$2.91M |
| Stock Issued | Q1 2026 · Mar 5, 2026 | 255.05K sh |